Laurus Labs Ltd

Extending its winning streak to two sessions, Laurus Labs Ltd touched a fresh all-time high of Rs 1,858.95 on 05 Aug 2026, marking a significant milestone in its price journey amid strong multi-timeframe momentum.

Surging past its previous peaks, Laurus Labs Ltd reached a new 52-week high of Rs 1840.45 on 4 Aug 2026, marking a remarkable 113.03% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained earnings growth, setting the stage for a compelling price rally.

Extending its remarkable rally, Laurus Labs Ltd touched a fresh all-time high of Rs 1,840.30 on 4 Aug 2026, outperforming the broader market and its sector with a 1.62% gain on the day against a Sensex decline of 0.49%.

Surging to a new 52-week high of Rs 1,829.7 on 3 Aug 2026, Laurus Labs Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market with a 115.57% gain over the past year. This milestone caps a seven-day winning streak that has propelled the stock 16.64% higher, underscoring the strength of its technical setup amid a cautiously optimistic market backdrop.

Extending its winning streak to seven consecutive sessions, Laurus Labs Ltd touched a fresh all-time high of Rs 1,828 on 3 Aug 2026, marking a remarkable rally that has outpaced the broader market by a wide margin.

Laurus Labs Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock recently hit a new 52-week and all-time high of Rs 1,826.6, outperforming its sector and reflecting strong investor confidence amid evolving market dynamics.

Surging past Rs 1812.1 on 31 Jul 2026, Laurus Labs Ltd has marked a significant milestone by reaching a fresh 52-week high, propelled by a confluence of robust technical indicators and sustained price momentum that outpaces its sector and the broader market.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 31 July 2026 as its stock price surged to an all-time high of Rs.1800. This landmark event reflects the company’s robust performance and sustained market momentum over recent periods.

With a sustained five-day rally culminating in a new 52-week high of Rs 1799 on 30 Jul 2026, Laurus Labs Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market. This milestone reflects a confluence of bullish technical indicators and steady fundamental performance that has propelled the stock to fresh highs.

Extending its winning streak to five consecutive sessions, Laurus Labs Ltd surged to a fresh all-time high of Rs 1,799 on 30 Jul 2026, outperforming its sector and the broader Sensex with a 0.49% gain on the day.

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Surging to a new all-time high of Rs 1791.5 on 29 Jul 2026, Laurus Labs Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 96.37% gain over the past year. This milestone caps a four-day winning streak that has propelled the stock well above all key moving averages, signalling robust technical health.

Laurus Labs Ltd has reached a significant milestone by touching an all-time high price of Rs.1769 on 29 July 2026, marking a remarkable achievement in the pharmaceuticals and biotechnology sector. This peak reflects the company’s sustained strong performance and robust financial metrics over recent quarters.

Surging to a new 52-week high of Rs 1746 on 28 Jul 2026, Laurus Labs Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market with a 95.81% gain over the past year. This milestone caps a three-day winning streak that has delivered a 10.57% return, underscoring the stock’s robust technical positioning amid a largely flat Sensex backdrop.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 28 July 2026. The mid-cap company demonstrated strong investor interest with a total traded volume exceeding 11.4 lakh shares and a turnover nearing ₹197 crores, reflecting heightened market participation and sustained momentum in its share price.

Laurus Labs Ltd has reached a significant milestone by touching its all-time high price of ₹1,735.50 on 28 July 2026, marking a new peak in the company’s market valuation and reflecting its robust performance in the Pharmaceuticals & Biotechnology sector.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, coinciding with a robust price rally that saw the stock hit a new 52-week and all-time high of Rs 1,730.9. This sudden increase in market participation and positioning signals heightened investor interest and potential directional bets on the stock’s near-term trajectory.

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment on 27 Jul 2026, signalling heightened market activity and potential directional bets. The stock also hit a new 52-week and all-time high of Rs 1709.6, outperforming its sector and broader indices, reflecting robust investor confidence and evolving market positioning.